<?xml version='1.0' encoding='utf-8'?>
<record xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
			<header>
				<identifier>oai:aavptbiennial-ojs-tamu.tdl.org:article/123</identifier>
				<datestamp>2024-10-30T18:54:12Z</datestamp>
				<setSpec>aavptbiennial:SI</setSpec>
			</header>
			<metadata>
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en">Statistical Considerations in the Interpretation of Clinical Trials: an Overview</dc:title>
	<dc:creator xml:lang="en">Powers, Jean D.</dc:creator>
	<dc:subject xml:lang="en">clinical trial design</dc:subject>
	<dc:subject xml:lang="en">control</dc:subject>
	<dc:subject xml:lang="en">data analysis</dc:subject>
	<dc:subject xml:lang="en">efficacy</dc:subject>
	<dc:subject xml:lang="en">toxicities</dc:subject>
	<dc:description xml:lang="en">Thus far, our discussions have covered some of the aspects which must be taken into consideration in the design of clinical trials. These include the need for randomization of patients, types of controls, and the need for blinding. Everyone even peripherally associated with clinical trials appreciated being reminded of the characteristics and properties of randomized block design. All too often we, as statisticians, "reach for" a parametric procedure to evaluate the data when really we "know" a nonparametric test is what we should be using. This is like the clinician who "reaches for" the treatment before making the diagnosis. It goes without saying that each one of us needs to be reminded periodically that a correlation coefficient that is statistically different from zero is not tantamount to a cause and effect relationship. &amp;nbsp;</dc:description>
	<dc:publisher xml:lang="en">AAVPT Biennial Symposia</dc:publisher>
	<dc:date>1982-04-13</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://aavptbiennial-ojs-tamu.tdl.org/aavptbiennial/article/view/123</dc:identifier>
	<dc:source xml:lang="en">AAVPT Biennial Symposia; Third Symposium; 61-63</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://aavptbiennial-ojs-tamu.tdl.org/aavptbiennial/article/view/123/117</dc:relation>
	<dc:rights xml:lang="en">Copyright (c) 1982 American Academy of Veterinary Pharmacology and Therapeutics</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		
